Antibiotic Prophylaxis for Prostate Biopsy

First-Line Recommendations

• The European Association of Urology recommends targeted prophylaxis based on rectal swab culture when possible, or include alternative antibiotics such as fosfomycin trometamol, cephalosporins, or aminoglycosides when targeted prophylaxis is not feasible 1, 2, 3
• Fosfomycin trometamol (3g before and 3g 24-48 hours after biopsy) is recommended as an alternative to fluoroquinolones 1, 2, 3, 4
• Cephalosporins (e.g., ceftriaxone 1g intramuscularly or cefixime 400mg orally for 3 days starting 24 hours before biopsy) are recommended as an alternative to fluoroquinolones 1, 2, 3
• Aminoglycosides (e.g., gentamicin 3mg/kg intravenously or amikacin 15mg/kg intramuscularly) are recommended as an alternative to fluoroquinolones 1, 2, 3

Evidence Supporting Recommendations

• The European Association of Urology 2024 guidelines explicitly recommend targeted prophylaxis as the first choice for transrectal prostate biopsy 1, 2, 3
• Historically, ciprofloxacin was the standard prophylactic antibiotic for prostate biopsy, but increasing fluoroquinolone resistance has necessitated alternative approaches 5, 6

Duration of Prophylaxis

• For fosfomycin trometamol, a two-dose regimen (pre-biopsy and 24-48 hours post-biopsy) is recommended 1, 2, 3, 4
• For cephalosporins, either single-dose parenteral (ceftriaxone) or multi-day oral regimens (cefixime) are options 1, 2, 3

Special Considerations

• Augmented prophylaxis (using multiple rather than single antibiotics) may be considered in high-risk patients, though this approach contravenes antibiotic stewardship principles 1, 2, 3
• The indication for fosfomycin trometamol for prostate biopsy has been withdrawn in some countries, so clinicians should check local guidance 1, 2, 3

Algorithm for Antibiotic Selection

• If rectal swab shows susceptible organisms, provide targeted antibiotic based on susceptibility results 1, 2, 3
• If rectal swab shows resistant organisms or targeted prophylaxis is not feasible, consider fosfomycin trometamol, cephalosporin, or aminoglycoside 1, 2, 3, 4

Prophylactic Antibiotic Regimens for TRUS Biopsy

Introduction to Prophylactic Antibiotic Selection

• The American Urological Association recommends prophylactic antibiotics for all patients undergoing TRUS biopsy, with a Level of Evidence: Ib, due to high post-biopsy infection rates without prophylaxis 7, 8

Evidence-Based Antibiotic Selection

• Single-dose or one-day regimens are as effective as three-day regimens for standard prophylaxis, with multiple RCTs confirming equivalence between single-dose and three-day dosing 7, 8
• The optimal approach is targeted prophylaxis based on rectal swab culture when feasible, although this is not always feasible 7, 8

Duration and Efficacy of Prophylaxis

• Fosfomycin requires a specific two-dose regimen (pre- and post-biopsy) 7, 8
• Combination regimens significantly reduce infection rates in high-risk settings or areas with high fluoroquinolone resistance, with any combination regimen showing significantly lower infection rates than any single-agent regimen (OR 4.0; 95% CI 1.47-10.85; P=0.004) 7, 8

Antibiotic Prophylaxis for Prostate Biopsy

Recommended Regimens

• The American Urological Association recommends gentamicin 5 mg/kg IV as a single dose or ceftriaxone 1-2g IV as a single dose, administered 30-60 minutes before the procedure for standard-risk patients 9
• For high-risk patients, the European Association of Urology suggests ampicillin 2g IV plus gentamicin 1.5 mg/kg IV as an alternative regimen 9
• Ceftriaxone 1-2g IV single dose is highly effective and convenient due to once-daily dosing, as recommended by the American Urological Association 9
• The American Urological Association also recommends cefazolin 1g IV as an alternative, but it requires dosing every 8 hours if extended prophylaxis is needed 9, 10

Special Considerations

• The American Urological Association advises against using first-generation cephalosporins alone for prostate biopsy prophylaxis due to inadequate gram-negative coverage 9
• For patients with orthopedic prostheses, the American Urological Association recommends ampicillin 2g IV plus gentamicin 1.5 mg/kg IV 9

Timing and Administration

• The American Urological Association recommends administering IV antibiotics 30-60 minutes before the procedure to ensure adequate tissue and serum concentrations at the time of biopsy 9

Antibiotic Prophylaxis for Transrectal Prostate Biopsy

Standard Single‑Dose Fluoroquinolone Regimen

• For men aged 50–80 years with normal renal function and no fluoroquinolone allergy, a single oral dose of ciprofloxacin 500 mg or levofloxacin 500 mg given 30–60 minutes before biopsy provides adequate prophylaxis, and antibiotics are not required beyond 24 hours post‑procedure. [11][12]13
• Single‑dose fluoroquinolone prophylaxis remains the preferred approach when local E. coli fluoroquinolone resistance is < 10–20 %. [11][12]13
• First‑line oral options for standard‑risk patients are ciprofloxacin 500–750 mg or levofloxacin 500–750 mg as a single dose administered 30–60 minutes before the biopsy. [11][12]

Duration of Prophylaxis

• Antimicrobial prophylaxis should be limited to a single pre‑procedure dose or discontinued within 24 hours after biopsy; extending therapy offers no additional benefit and raises the risk of antimicrobial resistance. [14][11]12

Timing of Administration

• Oral fluoroquinolones should be taken 60 minutes before the procedure, whereas IV fluoroquinolones require administration 120 minutes prior to incision to achieve adequate tissue concentrations. [11][12]

When Fluoroquinolones Are Not Appropriate

• If local fluoroquinolone resistance exceeds 10–20 % or rectal‑swab culture identifies resistant organisms, alternative agents should be used. 13
• Fluoroquinolones should not be used empirically when resistance is > 10 %, as this markedly increases post‑biopsy infection risk. 13

Alternative Prophylactic Agents for High‑Resistance Settings

• Ceftriaxone 1 g intramuscularly as a single dose is recommended when fluoroquinolone resistance is high. 14
• Amikacin 15 mg/kg intramuscularly as a single dose is another alternative in high‑resistance environments. 14

Safety in Patients with Beta‑Lactam Allergy

• Fluoroquinolones and aminoglycosides can be safely employed in individuals with documented beta‑lactam allergy. [11][12]

Dosing Considerations for Normal Renal Function

• Adults weighing > 40 kg with normal renal function receive standard dosing without adjustment (e.g., ciprofloxacin 500–750 mg oral single dose, levofloxacin 500–750 mg oral single dose, ceftriaxone 1–2 g IV/IM single dose, gentamicin 5 mg/kg IV single dose, amikacin 15 mg/kg IM single dose). 14
• Obesity may warrant dose modification, but routine adjustment is not required for single‑dose prophylaxis. 14

Resistance Surveillance and Targeted Prophylaxis

• Ongoing surveillance of local fluoroquinolone resistance patterns is essential because rising resistance directly diminishes prophylactic efficacy. [11][12]13
• When feasible, targeted prophylaxis based on rectal‑swab culture is the optimal strategy to tailor antibiotic choice to patient‑specific flora. 13

Common Pitfalls to Avoid

• Do not extend prophylaxis beyond 24 hours post‑biopsy, as this increases resistance without improving outcomes. [14][11]12
• Avoid aminoglycosides in combination with other nephrotoxic drugs, given uncertain prostate penetration and potential renal toxicity. 14